InMed Pharmaceuticals (INM) Gross Profit (QoQ) (2022 - 2025)
InMed Pharmaceuticals (INM) Gross Profit (QoQ) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.13 Bn | 20.97 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | InMed Pharmaceuticals | 7.25 Mn | 2.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -54.31% |
| Sep 30, 2025 | -30.09% |
| Jun 30, 2025 | 228.34% |
| Mar 31, 2025 | -61.89% |
| Dec 31, 2024 | -6.59% |
| Sep 30, 2024 | 5.87% |
| Jun 30, 2024 | 61.02% |
| Mar 31, 2024 | -10.70% |
| Dec 31, 2023 | 1,425.95% |
| Sep 30, 2023 | -98.65% |
| Jun 30, 2023 | 715.74% |
| Mar 31, 2023 | 46.77% |
| Dec 31, 2022 | 126.71% |
| Sep 30, 2022 | -296.63% |
| Jun 30, 2022 | 37.00% |
| Mar 31, 2022 | 63.40% |